32 results
POS AM
SYRE
Spyre Therapeutics Inc.
26 Mar 24
Prospectus update (post-effective amendment)
6:30pm
parties (such as through a cybersecurity breach) of our trade secrets or proprietary information could enable competitors to duplicate or surpass our … (such as acquisitions or integrations) could expose us to additional cybersecurity risks and vulnerabilities, as our systems could be negatively affected
POS AM
SYRE
Spyre Therapeutics Inc.
14 Mar 24
Prospectus update (post-effective amendment)
4:12pm
a cybersecurity breach) of our trade secrets or proprietary information could enable competitors to duplicate or surpass our technological achievements, thus … expose us to additional cybersecurity risks and vulnerabilities, as our systems could be negatively affected by vulnerabilities present in acquired
POS AM
tdgsw9a6
5 Mar 24
Prospectus update (post-effective amendment)
5:15pm
PRER14A
tzxo21uxqs0
6 Oct 23
Preliminary revised proxy
9:40pm
PRE 14A
nilgs4kces h4zm6o
7 Apr 23
Preliminary proxy
4:02pm